You are here

PIB NO: 17.086 for Neuro Angiography Room for Israel

1 post / 0 new
jtahmas
Offline
Last seen: 16 hours 37 min ago
Joined: 01/12/2012 - 14:36
PIB NO: 17.086 for Neuro Angiography Room for Israel

USAID PROCUREMENT INFORMATION BULLETIN
PIB NO:  17.086 for Neuro Angiography Room  for Israel
DATE: 20 OCT 2017

________________________________________________________
Office of Acquisition Assistance Washington, D.C. 20523
________________________________________________________

Sealed bids to provide the following goods will be received by the Hadassah Medical Organization Jerusalem until 4 pm Israeli Time on Monday 4th  of December  2017. All bids will be opened and reviewed at a time of Hadassah’s choosing thereafter.

 

Item: Neuro Angiography Room  (Cath lab) QTY: 1

Description: This state-of-the-art Neuro Angiography Dual Plane Room will be used for Angiographic Examinations of the Head and Neck 

Authority: AID Grant AID-ASHA-G-16-00019

 

 

A purchase order contract is intended to be awarded to the lowest responsive responsible bidder on a firm fixed price basis. The proposed contract document is an addendum to this solicitation. Bidders are encouraged to thoroughly examine the terms and conditions in the proposed contract before submitting a bid. Funds to pay the cost of this procurement have been made available by the United States Agency for International Development (USAID) which requires that certain laws and regulations referenced in the contract apply to the transaction (2 CFR 200.326 and 2 CFR 200, appendix II as applicable). A copy of these USAID regulations is found at https://www.ecfr.gov/cgi-bin/text-idx?SID=443f7bd380f9652545eb676b1051e920&mc=true&node=ap2.1.200_1521.ii&rgn=div9.  In addition, the items furnished must comply with requirements for source and nationality of commodities and services financed by USAID (22 CFR 228, issued 1/10/12). A copy of these USAID regulations is found at https://www.ecfr.gov/cgi-bin/text-idx?SID=443f7bd380f9652545eb676b1051e920&mc=true&tpl=/ecfrbrowse/Title22/22cfr228_main_02.tpl

 

Hadassah reserves the right to waive technicalities or defects or to reject any and all bids. All bids received and accepted shall be binding for a period of 180 days after the deadline identified above. A bidder may withdraw a submitted bid prior to the deadline date identified above in which case that bid will not be considered.  Any questions concerning the above description or specifications shall be submitted to Anita Rotenberg. Hadassah may make such inquiries as it deems necessary to determine the ability of any bidder to provide the items sought including the conduct of vetting against data bases maintained by the United States Government whose funds are being used by Hadassah to make the purchase.

 

Date:  October 25,  2017

                       

US Authorized Geographic code: 937                            

Country:              Israel

 

Purchasing agent

or Entity:            Hadassah Medical Organization

                             Kiryat Hadassah

                             P.O.B. 12000

                             IL-91120 Jerusalem, Israel

                             Fax: 011-972-2-6780821

 

To obtain a copy of the solicitation including the terms and specifications, please send a request to the Hadassah Medical Organization in Israel at  Anita@Hadassah.org.il

 

Please specify the equipment requested. Upon receipt of your request, a copy of the solicitation will be sent to you by email.

All manufacturers' warranties on proposed equipment must be honored in Israel.  The quotation must contain the name of a reliable Israeli agent that can carry out the terms of the warranty and who can be used for installation (if needed), spare parts and other services.

In order for a quote to be responsive to this notice, suppliers are required to provide a copy of the applicable approval letter from FDA, covering medical devices that require pre-market approval in the US and the Israeli equivalent of FDA approval which is known as AMAR

Additionally, the supplier shall provide the following certification:

“The undersigned supplier agrees and certifies that all products provided are covered by a valid FDA approval letter and/or otherwise are in compliance on the date of shipment with all applicable United States laws and regulations governing the delivery of regulated products in interstate commerce.”

 

Please send your request to Anita Rotenberg anita@hadassah.org.il

 

Attachments: